World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Aug 10
Underlying Viral Infection Identied By Genomic Signature In Blood
Scientists have identified a genomic "signature" in circulating blood that reveals exposure to common upper respiratory viruses, like the cold or flu, even before symptoms appear.

The tell-tale viral signature reflects a set of subtle but robust changes in genes that are activated as the body responds to infection. The signal from the signature is strong enough in symptomatic individuals to clearly reveal whether their infection is viral or bacterial. It can also discriminate between who has a viral infection and who does not - all from a single tube of blood.

"This work is still in a relatively early phase of discovery, but we are optimistic that these findings may lead to a whole new way of diagnosing infectious disease," says Geoffrey Ginsburg, M.D., Ph.D., director of Duke University's Center for Genomic Medicine in the Institute for Genome Sciences & Policy and the senior author of the study appearing in the journal Cell Host & Microbe.

Researchers say the discovery could lead to dramatic changes in the way doctors care for the millions of people who develop upper respiratory infections every year. Ginsburg says the symptoms of a cold, the flu or pneumonia can appear similar, but right now, doctors can't tell what the patient really has until laboratory tests are conducted, and that can take days.

"Until results are in, treatment is pretty much a best guess. Knowing exactly which pathogen is involved is important because it affects the urgency of response and the type of treatment," says Ginsburg. "This approach could lead to more precise, informed and tailored therapy - essentially, personalized care for infectious disease. That's better for the patient and better for public health, in general."

Christopher Woods, M.D., an associate professor of medicine at Duke and the Chief of the Infectious Disease Section at the Durham Veterans Administration Medical Center, says a quick test to determine the real cause of disease has other benefits, too. "It could mean more appropriate use of antibiotics. Overuse of antibiotics can lead to the emergence of drug-resistant pathogens, and no one wants to see more of that."

The discovery is based upon the fact that the body's immune system starts responding very quickly and in a highly specific manner when exposed to a viral pathogen as opposed to a bacterial one. "A detailed reading of that response, using gene expression data, reveals what type of pathogen the person is reacting to," says Aimee Zaas, M.D., M.H.S., an infectious diseases physician at Duke and the lead author of the study.

Zaas and colleagues recruited 57 healthy volunteers who agreed to be inoculated with either a live cold virus (rhinovirus), the respiratory syncytial virus, or the influenza A virus. Researchers first took detailed baseline measures of genomic profiles in participants' blood, nasal fluid, breath and urine, and then inoculated the volunteers with one of the three viruses. They waited to see who became sick, and noted when symptoms first appeared, measuring markers of biological response at multiple time points after exposure. Volunteers were quarantined during the time they were infectious.

The research team studied changes in gene expression patterns in the participants' blood and identified 30 genes - many of which were already known to be active in the body's response to viral infections - whose expression patterns changed only among those who became symptomatic.

Investigators tested this "acute respiratory viral signature" in an independently acquired data set of gene expression patterns among people infected with influenza A and found that the signature was able to clearly distinguish with 100 percent accuracy between individuals who were infected and those who were not.

The researchers say the acute viral response signature may be applicable only to people who have healthy immune systems. "We would need to show that this approach also works in patients with underlying immune deficiencies before we could offer it as a potential diagnostic tool for everyone," says Zaas.

Aug 10
New Tool May Help With Early Detection Of Deadly Pancreatic Cancer
A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing it in its early stages. The method, which studies carbohydrate structures in the bloodstream, could lead to the development of blood tests that can detect cancer more effectively.

"Tumor cells sometimes shed proteins into a patient's bloodstream," said VARI Senior Scientific Investigator Brian Haab, Ph.D., whose lab published its findings in the journal Molecular & Cellular Proteomics. "These proteins can have carbohydrate structures attached to them that might be able to tell us not only if a patient has cancer, but also more about the cancer and how to treat it."

Associating specific carbohydrate alterations on proteins with cancer could provide better cancer detection than the measuring of protein levels alone, the current, most-commonly-used method of blood testing for many types of cancer. Haab said that specific alterations also could be connected to specific cancer characteristics, such as the ability to spread or resistance to therapy. Some carbohydrate alterations also could have distinct functions in cancer progression, which might have therapeutic value.

Researchers used the method to study blood samples from pancreatic cancer patients at Evanston Northwestern Healthcare in Illinois. They identified the prevalence of a variety of alterations on different proteins.

"Interestingly, the protein with the most alterations was not previously recognized as a marker for pancreatic cancer, perhaps because the protein level alone did not provide good cancer detection," said Tingting Yue, a Michigan State University graduate student working at VARI and lead author of the study. "This protein is found in pre-malignant lesions and could be valuable for early detection if we can find unique alterations associated with it."

Aug 10
Swine flu deaths go up in India
The number of people to die of swine flu in India has risen to six with the death of a number of patients over the weekend, health officials say.

Six patients are reported to be in a serious condition in the western city of Pune, which has recorded more cases than anywhere else in India.

A number of schools in the country have been shut temporarily over fears of children contracting the disease.

Officials say there are more than 800 cases of the H1N1 flu strain in India.

The virus is thought to have killed almost 800 people around the world.

A 53-year-old doctor of indigenous medicine and a four-year-old boy died in hospitals in western Pune and southern Chennai cities early on Monday, taking the number of deaths caused by swine flu to six.

Over the weekend, three people died of the flu in western India - a 43-year-old businessman who was visiting Ahmedabad city in Gujarat state; a 42-year-old teacher in Pune city; and a 53-year-old woman in Mumbai city.

Last Monday, a 14-year-old girl became the first person in the country to die of swine flu.

Rising concerns

Health officials say that the country had enough stocks of the anti-flu drug Tamiflu.

However, panic is growing among the people with swine flu deaths making it to the front pages of newspapers and main TV news.

Several schools in western Indian and the capital, Delhi, have closed temporarily as fears grow about children contracting the flu.
A shop owner wearing a mask in Mumbai
Panic is growing among the people with swine flu fears rising

In Delhi, where some 228 cases have been confirmed, health officials say that the people are panicking "because the symptoms of swine flu and common influenza are similar".

As the number of flu deaths rise in the country, health officials have asked people not to panic.

Indian PM Manmohan Singh has asked the health ministry to step up preparedness against the disease and coordinate with state governments to help stop the disease spreading.

"All state governments have been asked to set up their own swine flu helplines, create more quarantine wards not only in their hospitals but also in the big private hospitals," federal Health Minister Ghulam Nabi Azad said.

The BBC's Soutik Biswas in Delhi says though the number of swine flu deaths in India was still low, there are concerns over the ability of the badly-run and under equipped government hospitals to handle the rising tide of patients.

Also, the 12 swine flu testing centres in India will not be sufficient if the number of cases rise sharply, our correspondent says.

"We need to work out a public-private partnership between the hospitals to tackle the flu. We need to take the people, doctors and media into confidence so panic does not spread," federal Junior Health Minister Dinesh Trivedi.

Last week, the World Health Organization announced that the first swine flu vaccines are likely to be licensed for use in the general population in September.

The swine flu (H1N1) virus first emerged in Mexico in April and has since spread to 74 countries.

Aug 08
Never Too Late For Angina Patients To Change, Says British Heart Foundation
In response to a study published in the BMJ that examined the risk factors for deaths from heart disease for patients with angina, British Heart Foundation (BHF) Associate Medical Director Dr Mike Knapton said:

"This study of 1800 people living with angina in Scotland showed that those who were most likely to die from heart disease were male, older, obese or smokers.

"This is the first time this has been demonstrated in a large number of patients living in the community, rather than in hospital settings, and confirms that smoking and being obese greatly up your risk of dying from heart disease.

"This is good news for people living with angina, as it shows that it's never too late for them to change their lifestyles, or to stop smoking."

Aug 08
Prevention, Vaccines Addressed At IAS Conference
During the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa, scientists "renewed the call for more immediate and urgent effort to be directed towards HIV prevention amid the dominance of treatment interventions and the world-wide search for a quick fix vaccine, which many agree, is years away," Health-e/allAfrica.com reports (Thom, 7/22).

Data was presented from ongoing trials of microbicides and Pre-Exposure Prophylaxis trials, including a Phase III trial on the microbicide Pro2000 involving more than 9,389 women and an "adherence and drug absorption study" that looks at "whether antiretrovirals (ARVs) can be used effectively for HIV prevention in the form of a applicator gel or a pill that can be taken orally once a day - also known as PrEP.

The Times of Zambia/allAfrica.com examines the announcement by scientists representing the Microbicide Trials Network at the conference about plans for a large-scale microbicide clinical trial involving about 5,000 women from Zambia, Uganda, Malawi, Zimbabwe and South Africa. The trial is expected to take about three and half years, with results available in 2012, a co-chair of the study said.

François Venter, president of the Southern African Clinicians Society, "said though the research shows promise there are numerous issues that need to be addressed," the Health-e/allAfrica.com writes, including accessibility of products and the "uncertainty on whether developing countries will be able to afford providing PrEP to patients not yet infected when they are currently struggling to provide treatment to those already infected".

Executive director at the Center for Evaluation Research and Surveys at the National Institute of Public Health in Mexico, "said greater emphasis needed to be placed on getting value from investments," which would require "a shift in thinking from a short-term emergency response to a more efficient, long-term approach." An analysis of 28 "completed biomedical prevention trials" revealed "only four, including three trials of male circumcision, have reported significant efficacy," according to Robert Gray of Johns Hopkins, who "argued for conducting fewer trials, but with a greater investment in rigor and quality,".

Aug 08
WHO sends virus, India begins work on swine flu vaccine
India has joined the international community’s effort to make a vaccine for the H1N1 pandemic that has affected 135 countries in the world.

The virus strains reached the country last week from the World Health Organisation and two New Delhi-based drug companies have started work. Officials said the indigenous vaccine will take about “three to four months” to manufacture — the same duration in which international drug manufacturers have promised to deliver the vaccine. The WHO has said that the vaccines will be available by this autumn.

As of now, the Government has granted licences for the H1N1 vaccine to three companies, Serum Institute of India, Panacea Biotec and Bharat Biotech.

While Serum Institute of India, already a WHO-recognised vaccine manufacturing unit and Panacea Biotec have got the “A” (H1N1) virus strains from WHO, Bharat Biotech is waiting for its strains.

Said V M Katoch, Secretary, Department of Health Research and DG ICMR: “Vaccine manufacture takes a minimum of three to four months, our vaccine will also take around the same time. It’s a part of international rapid response and things have to be hastened in response to a pandemic.” According to Katoch, this is part of the government’s plan to have its own indigenous vaccine.

With the pandemic spreading and over 70 per cent of the international manufacturing units being in Europe, the government wants to ensure that Indians get their vaccines on priority. “We have committees set up which will negotiate with the industry and also monitor the process. We want to ensure that our people get priority and once our need is met, firms can export the vaccines,” Katoch said.

Aug 06
ER Physician Tells You How To Avoid A Lightning Strike And What To Do If One Occurs
An estimated 200 people die each year in the U.S. after being struck by lightning. An extremely brief but intense hit delivers more than 10 million volts and is fatal in about 30 percent of cases. Recent lightning strikes in Newark resulted in one death and three injuries.

Most survivors have significant complications. Half of people struck by lightning will suffer rupture of the tympanic membrane in the ear. Many go on to develop cataracts.

"Lightning presents a grave risk of death," warns Shreni Zinzuwadia, M.D., an emergency department physician at UMDNJ-The University Hospital and instructor of surgery at the UMDNJ-New Jersey Medical School. "Cardiac or respiratory arrest may result from being hit by lightning."

There are other dangers outside of a direct hit, she added, from three additional types of strikes.

A side strike happens when lightning jumps from its initial point of contact to the victim. "For example, if you seek protection under a tree, which is one of the worst places to be during a storm, the lightning can hit the tree then jump to you, a better conductor of electricity since humans are mostly salty water," she explained. "This kind of strike can kill the tree and the person."

A contact strike occurs when lightning hits an object the person is holding or wearing, such as a watch or eyeglasses.

The other type of strike - step potential happens when a current traveling through the ground goes up your leg, travels through you and then goes down the other leg and back into the ground. "That is why Boy Scouts practice standing on one leg during a storm," she explained. "They are attempting to decrease the likelihood that the current will go through them by having only one foot on the ground."

Prevention begins by seeking cover at the start of a storm. "Lightning seems to be concentrated at the forefront of a storm," according to Zinzuwadia, "so there tends to be a greater risk of being hit by lightning at the beginning of a storm."

According to the Federal Emergency Management Agency (FEMA), part of the U.S. Department of Homeland Security (DHS), individuals who hear thunder roar should go indoors because no place outside is safe when lightning is in the area. Stay indoors until 30 minutes have passed after you hear the last clap of thunder.

Once inside, FEMA advises that people avoid contact with corded phones and electrical equipment or cords; do not wash your hands, take a shower, wash dishes, or do laundry because plumbing and bathroom fixtures can conduct electricity; stay away from windows and doors; stay off porches; and do not lie on concrete floors or lean against concrete walls.

If you are outside during a storm, crouch down and try to touch as little of the ground as you can, Zinzuwadia suggests. "Even if you are hit by the current, the less contact there is between you and the ground, the less likely it is that all of your major organs will be hit," she says. "It increases your chances of survival."

What signs might indicate that a person has been struck by lightning? "You may see superficial burns on the skin or clothing may burst into flames or be torn away from the body," Zinzuwadia said. "A person may fall to the ground.

"People who are hit by lightning commonly die from ventricular fibrillation, asystole (cardiac arrest), or respiratory arrest," Zinzuwadia added. "Bystanders should immediately check for a pulse and spontaneous breathing."

If a person is in respiratory arrest has a pulse but is not breathing - provide rescue breaths until the victim resumes spontaneous breathing.

If the victim goes into cardiac arrest, where the heart just stops due to the impact of the massive electrical current, CPR should be administered, Zinzuwadia said. "Give cardiac compressions and provide respiratory support for them."

Aug 06
Gut Hormone Has 'Remote Control' On Blood Sugar
A gut hormone first described in 1928 plays an unanticipated and important role in the remote control of blood sugar production in the liver, according to a report in the August 6th Cell Metabolism, a Cell Press publication. What's more, the researchers show that rats fed a high-fat diet for a few days become resistant to the glucose-lowering hormone known as cholecystokinin (CCK).

"We show for the first time that CCK from the gut activates receptors to regulate glucose levels," said Tony Lam of the University of Toronto. "It does so via a gut-brain-liver neuronal axis."

Researchers already knew that CCK levels rise in the upper intestine in response to nutrients such as lipids to lower food intake, Lam explained. Now, his team shows that the CCK hormone binds local receptors on nerves of the small intestine, sending a powerful signal to the brain. The brain in turn tells the liver to stop producing glucose.

Lam said his group described the gut-brain-liver circuitry in a paper published last year. The new study shows that it is CCK that acts as the trigger.

A primary increase of CCK-8, the biologically active form of CCK, in the upper intestine lowers glucose production independently of any change to circulating insulin levels, they found. CCK-8's effects depend on activation of CCK-A receptors and the signals they send to the brain and on to the liver, where glucose production slows. Those effects of the hormone begin to fail early in the onset of high-fat diet-induced insulin resistance, they report.

The findings suggest that CCK resistance, like insulin resistance, might be a key contributor to the high blood sugar that often comes with a high-fat diet. It also suggests that drugs targeting the CCK receptors in the gut may hold promise for therapy. That's key, Lam said, because such gut-targeted drugs might be expected to have fewer side effects than currently available diabetes drugs that work directly on the liver.

"This raises the possibility that we might be able to tap into the circuitry [to lower blood sugar]," Lam said. "At least now we know where to start."

Drug combinations that could increase sensitivity to both insulin and CCK might better combat diabetes than either could alone, he added. While the magnitude of CCK's influence over glucose levels relative to the effects of insulin aren't yet known, Lam said it's now clear both are important and neither works properly in the case of diabetes or obesity.

The researchers further suggest that CCK's role in the gut might somehow explain why people often show improvements in their blood sugar levels following gastric bypass surgeries, even before they lose any weight.

"Since we described that duodenal CCK normally triggers a gut-brain-liver axis to lower glucose production but fails to do so in high-fat fed rodents, we propose that duodenal bypass surgeries improve glucose tolerance in diabetes and obesity partly because the surgery bypasses an acquired defect involving duodenal CCK resistance in response to high-fat feeding," they wrote. Further studies are needed to explore that notion.

Aug 06
Despite Repeat Warnings, Skin Cancer Continues To Rise Among Women
Do you intend on getting a healthy tan this summer? You may want to rethink your plans. Tan skin is the body's reaction to sun damage, along with freckles, wrinkles and brown spots. So unless your tan comes from a bottle, it's probably not healthy.

More than one million cases of skin cancer will be diagnosed in the United States this year, according to the American Cancer Society. And despite the countless public service announcements and media messages, the numbers continue to rise.

According to recent studies by both the American Academy of Dermatology and British Association of Dermatologists, people in their teens and early twenties are less likely than any other age group to use sun protection, despite the increasing risk among this demographic.

Many young people ignore the risk because they don't see the detrimental effects of the sun right away. Skin cancer often does not show up immediately. "Most skin cancers take years of cumulative sun exposure to form and reflect sun-worshipping behaviors of years past," says Tanya Futoryan, MD, medical director of the Westport Dermatology and Laser Center in Westport, Conn.

And it's not just young people who suffer the negative effects of the sun. It's only been over the last two decades, that we've learned, as a society, about the dangers of the sun. Millions of women who spent their childhoods basking in the sun are suffering the consequences as well.

"Although we are better educated now on sun protection, it takes a long time to adapt sunscreen use and sun avoidance into our every day lives," says Futoryan. "Every new generation has to be convinced of the dangers of sun damage."

There are three major types of skin cancer. Bad sunburns which include blistering increase a person's risk of melanoma, the most serious type of skin cancer. Long-term exposure to the sun increases the risk of all types of skin cancer including the less serious types: basal-cell and squamous-cell carcinoma.

The diagnosis of all types of skin cancer has increased and melanoma has become the most common cancer among young women aged 25-29, according to the Centers for Disease Control and Prevention in Atlanta, Ga.

While it's not entirely clear why the risk of skin cancer is skyrocketing in women, there are certainly a few clues. Alarming numbers of young people, mostly women, are using tanning beds in the United States. Study after study suggests that the UV rays at tanning salons are just as damaging as natural sunlight.

"In young women ages 15-29, the torso is the most common location for developing melanoma, which may be due to high risk tanning behavior," according to Francesco Fusco, MD, assistant clinical professor of dermatology at Mt Sinai School of Medicine NYC and an educational spokesperson for the Skin Cancer Foundation. "This is most likely due to increased UV exposure which includes natural as well as artificial UV light."

There is also strong evidence suggesting that young people continuously ignore the threat of skin cancer. According to results from a recent study conducted by the American Academy of Dermatology, only one in three American teenagers between the ages of 12 and 18 used sunscreen.

"While great advances have been made in early detection and prevention of skin cancer, it is important to educate young women about the importance of sun protection in the fight against skin cancer," says Futoryan.

Here are some tips on how to stay safe in the sun:

- Use sunscreen (with broad spectrum UVA/UVB protection) liberally when outdoors.

- Seek shade between 10 am and 4 pm large sun umbrellas work great.

- Wear sun-protective clothing; hats and longer pants, shirts with sleeves, sarongs and wraps.

- Use UV absorbing sunglasses to protect the eyes.

In addition to your own monthly skin checks, an annual head-to-toe skin examination by a dermatologist, or skin doctor, should be a routine part of your health maintenance.

Aug 06
India may have its own H1N1 vaccine by September
India could have its very own indigenous vaccine against H1N1 influenza
by September.

Among three India companies — Serum Institute, Bharat Biotech and Panacea — working towards producing this India-specific vaccine, two have assured the health ministry that the vaccine would be ready by September-end. This was confirmed by director general of health services
(DGHS) Dr R K Srivastava.

He told TOI, “Two of these companies have told us that they will be able to provide the vaccine by September while the third one hasn’t given any time frame yet.” He added, “Once we are near to having the vaccine, we will decide who will get it first, how many vaccine doses we will require and what the regimens will be.”

The Indian Council for Medical Research (ICMR) and the National Institute of Virology in Pune
isolated the deadly H1N1 virus from a sample of India’s first human infection in Hyderabad on May 16. However CDC Atlanta, which grew what’s called a seed stock — a strain of the virus that’s the first step toward growing a vaccine — has sent it to the three manufacturers for the vaccine.

Health ministry officials said the vaccine should be available with India before the second wave of the pandemic arrives sometime in November. Dr V M Katoch, ICMR director general, told TOI, “For a pandemic vaccine there is no time to see its long-term effects. The manufacturers will ensure that the vaccine is safe and is effective. They will look at whether the human immune system is producing antibodies against the virus or not. We should therefore have a vaccine in the next three months.”

Browse Archive